Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Incyte Corporation
UNC Lineberger Comprehensive Cancer Center
West China Hospital
Lebanese University
OHSU Knight Cancer Institute
Emory University
Lebanese University